Aclarion Expands Nociscan Reach with Los Angeles Pain Clinic Partnership
Event summary
- Aclarion partners with Source Healthcare, a high-volume Los Angeles pain clinic, to expand Nociscan availability.
- Agreement strengthens real-world evidence generation comparing Nociscan to anesthetic discography.
- Source Healthcare treats chronic low back pain using Nociscan's non-invasive biomarker analysis.
- Nociscan demonstrates 97% surgical success rate when all positive discs are treated.
The big picture
Aclarion's partnership with Source Healthcare aligns with its strategy to expand Nociscan's reach in the pain management field, addressing a global healthcare problem affecting 266 million people. The deal underscores the shift toward non-invasive, biomarker-driven diagnostics in chronic low back pain treatment, potentially reducing reliance on invasive procedures like anesthetic discography. Success here could position Nociscan as a standard diagnostic tool in pain management.
What we're watching
- Adoption Dynamics
- How quickly Source Healthcare integrates Nociscan into its care pathways and whether it drives broader payer and provider adoption.
- Evidence Generation
- The pace at which real-world evidence comparing Nociscan to anesthetic discography accumulates and its impact on market positioning.
- Scalability
- Whether Aclarion can replicate this partnership model in other high-volume pain clinics to support its growth strategy.
Related topics